[Is PON1 a factor of cardiovascular risk in type 2 diabetes?]

Ann Cardiol Angeiol (Paris). 2016 Apr;65(2):81-6. doi: 10.1016/j.ancard.2015.02.006. Epub 2015 Mar 23.
[Article in French]

Abstract

Objective: We evaluate the association between the decrease of serum paraxonase 1 activity and the risk of cardiovascular disease in type 2 diabetes.

Methods: One hundred and fourteen patients with type 2 diabetes were included in the present study. Seventy-one of them have significant coronary disease. The control group consisted of 53 healthy adults.

Results: PON1 activity was significantly reduced in diabetic patients compared to controls (P=0.021), especially in those with significant coronary disease (P=0.013). No significant variation in PON1 activity according to age was observed both in controls and in patients. When HDLc≥1.03mmol/L, the PON1 activity was significantly higher in patients without significant coronary disease compared to those with significant coronary disease (0.030). In case of significant coronary disease, a decrease of 12.23% in PON1 activity was observed in smokers compared with non-smokers, but without statistical significance. The PON1 activity did not very significantly according to the presence or absence of hypertension in patients with significant coronary disease.

Conclusion: The implication of diabetes in the decrease of PON1 activity seems highly probable but PON1 activity seems not to be in itself a marker of cardiovascular disease.

Keywords: Cardivascular disease; Diabetes; Diabète type 2; PON1; Risque cardiovasculaire.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aryldialkylphosphatase / blood*
  • Biomarkers / blood
  • Body Mass Index
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / diagnosis*
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / complications*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Risk Factors
  • Sensitivity and Specificity

Substances

  • Biomarkers
  • Aryldialkylphosphatase